What is Protego Biopharma worth?
$216.5Mlast known valuation
Protego Biopharma last raised $32.9M in its Early Stage VC (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Protego Biopharma
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $32.9M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $51.0M | ▮ | ▮ |
| Dec 2019 | Seed Round | $1.0M | ▮ | ▮ |
How Protego Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Protego Biopharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Protego Biopharma worth?
- Protego Biopharma's last known valuation is $216.5M.
- How much has Protego Biopharma raised?
- Protego Biopharma has raised $182.1M in total funding across 3 recorded rounds.
- When did Protego Biopharma last raise?
- Protego Biopharma last raised in Oct 2025 (Early Stage VC), raising $32.9M.